Nasdaq · Healthcare
Synergy CHC Corp. (SNYR)
As-reported financials and recent SEC filings for Synergy CHC Corp., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$30.4M
Net income
$-12.3M
Net margin
-40.6%
Diluted EPS
$-1.27
ROE
53.4%
P/E (TTM)
—
Market cap
—
Debt / equity
-1.1×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2024 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $30.4M | $34.8M | $42.8M | $29.4M | $33.8M |
| Gross profit | $20.3M | $23.6M | $32.1M | $20.2M | $22.8M |
| Operating income | $-8.5M | $5.8M | $10.8M | $-8.0M | $-4.9M |
| Net income | $-12.3M | $2.1M | $6.3M | $-9.2M | $-6.2M |
| Diluted EPS | $-1.27 | $0.28 | $0.86 | $-1.20 | $-0.84 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-07-01
View on EDGAR →42026-07-01
View on EDGAR →42026-07-01
View on EDGAR →8-K2026-06-29
View on EDGAR →EFFECT2026-05-22
View on EDGAR →8-K2026-05-18
View on EDGAR →S-12026-05-15
View on EDGAR →8-K2026-05-14
View on EDGAR →Largest Healthcare peers
Go deeper on SNYR
Search Synergy CHC Corp.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.